疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

' A" x$ ]7 j7 A& x' [

Vaccines, 6th Edition

, c! b) k3 X! A) jApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

/ _& h" Y) U+ T( N4 t2 I. }; Shttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
9 ]9 ~4 D1 g9 ^# C1 T' N1 A short history of vaccination 1
6 P' J) y# D8 s2 O3 w. j1 X3 |2 Vaccine immunology 14
/ V8 G0 S" w1 Z+ [% F; g' s3 The vaccine industry 33
$ d7 O) D$ L1 Z9 r& D4 Vaccine manufacturing 44
0 X. S' w$ x5 m" H5 Evolution of adjuvants across the centuries 58
5 H3 C  q+ \' q. }7 m6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
& G2 q' J* }" U) _% ]- ~1 |8 General immunization practices 88
SECTION 2: Licensed vaccines
" w8 f7 ?9 c( m: I9 Adenovirus vaccines 113
2 D  F" E" m. }3 V; U# C  m  s$ {9 o10 Anthrax vaccines 127
# |3 g! L+ L$ U0 q" x  C11 Cholera vaccines 141
" o% w( n/ e7 I  r2 `/ R( O1 O0 `12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
, n  E2 e6 c; f9 D, T. S18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
1 f* C2 M( C/ J& [9 f  f- n+ P21 Meningococcal vaccines 388
% b+ d2 [) J4 K, [4 f22 Mumps vaccine 419
- C& U2 n& G/ S9 a. ?; S23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
1 Y- R! F: G$ I3 d9 h26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
  }: Z5 \4 K) j: f: V$ M29 Rabies vaccines .646
) F# N3 {' `/ I30 Rotavirus vaccines . 669
! _/ Y' j7 O& f" m1 }31 Rubella vaccine 688
32 Smallpox and vaccinia 718
' e! n3 c1 y$ j; x9 u& {33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
2 ]+ X5 m5 d7 L. c35 Tuberculosis vaccines 789
) V8 y, a2 q8 _6 w3 m36 Typhoid fever vaccines 812
, [7 F& [* ^# y! _37 Varicella vaccine 837
38 Yellow fever vaccine 870
+ [. K! Q6 b0 Q$ N8 ~. R39 Zoster vaccine 969
& v# [. d. u6 [40 Combination vaccines 981
) i" b) y3 W2 F% J- _! w5 OSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
6 W$ Q8 i% F8 P) S6 c. ^44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
( Y* U* i7 o7 r) K+ G48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
  T6 @8 r" {, ~1 X! n50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
& Q+ W! {; A) P( v( y- Z55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
1 p5 F  z) V$ {56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
( ]2 Y) c8 T% V4 x2 J58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
9 ], E. d( a+ h5 k9 |" k6 k: K60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
9 T% g& q% U) {# p% Y$ [  b# }8 ^62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
; r% z% B6 ^% R/ T63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
# D/ R' I/ z+ N' g, @3 R$ F65 Vaccines for international travel 1270
$ f/ B% f1 @; v( y% W66 Vaccines for health care personnel 1290
) q* @/ o- h" E8 H) bSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
3 l: A1 q: \$ U: H4 g5 W, M69 Immunization in the Asia-Pacific region 1353
( [1 w3 \) M2 t+ U/ x  t' ^1 O70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
* e: S% k: H$ O73 Regulation and testing of vaccines 1427
8 _; k, L& V' c6 F7 Y& K; Q74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
2 m! R$ K; h! u/ e* _  R77 Legal issues . 1481
78 Ethics 1508
! X  l( R+ `1 m8 G, Y3 ]. B
, ?/ t4 s  E0 f& w


& i8 w+ Z, G9 G3 p: ]' s

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition

: n! ^2 N1 k0 U, OApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
8 H& l5 }& x6 e! E# F
http://yun.baidu.com/share/link? ... 1&uk=3810996606
2 ?% r* I. `/ ^8 g( [8 \5 C$ O& u
" c# f1 K; O% Z; Y* x( G8 ]SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
$ ]+ ~, f2 F, P0 w: V6 I3 The vaccine industry 33
9 S: P, [. ]8 R3 |4 Vaccine manufacturing 44
2 e; w! V  o) ~, ~( i# c5 Evolution of adjuvants across the centuries 58
' _8 Z' r5 K. s5 D# l5 h  l% k6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
4 y# n  g) @' F4 R* a4 S1 A7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
, |; Q* i# ?( W( ^+ y5 ]" X* Q13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
; @9 ?! [2 q; @5 i16 Human papillomavirus vaccines 235
* v1 Z$ x' _: ^& n0 ~' G17 Inactivated influenza vaccines 257
7 s7 ?3 J' |: h' C6 e6 G; h; q" y18 Influenza vaccine-live 294
6 |% w, u1 c8 x+ I. W) \19 Japanese encephalitis vaccines 312
! ~6 _- g. U% b( k% j20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
  g; V0 _) `  K1 P8 K+ H# w24 Plague vaccines 493
- W) h1 H5 G7 M  u# F# g25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
% b: }) l: q4 l' L) ]$ T: \30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
: t5 Y/ W! ^# `% \2 x! W3 g& N34 Tick-borne encephalitis virus vaccines 773
- F3 c" @( X7 q4 K- G8 b! b35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
" Y  P; o( }8 E. n# D8 f: m39 Zoster vaccine 969
$ h. C4 W, {4 r! F6 c# ]40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
$ Z5 s( y6 Q1 |4 Z41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
" I  m5 L- L8 v" ?- A) e" Y44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
& G9 M9 H  p9 X' |  N# B) @46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
  B8 ~4 t$ D  V4 S1 v% t- ?& v. o48 Hepatitis C vaccines 1074
9 M  \9 O5 v7 H+ c" a# Y! e" ^49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
) a# t4 B* p, M2 M0 h5 n; B51 Human immunodeficiency virus vaccines 1097
9 {8 }5 q# i& u9 g52 Lyme disease vaccines 1122
' M1 z! b" Y( Y  `1 M6 {53 Malaria vaccines 1133
5 M0 v$ ~' _& i& X7 T54 Noninfectious disease vaccines 1138
5 i; h+ }* [7 n! ~6 a& _- C55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
. [9 e/ Y! @- x8 N" P% P56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
8 |% J' _& b: w/ h6 j. ?3 Y59 Streptococcus group B vaccines 1176
- q: S4 X: v5 _. H# w( v) u60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
+ ~4 [/ Z  ~2 C- S; W! H" q! N1 FSECTION 4: Vaccination of special groups
. I1 A& O3 y# Y2 Z# f/ @2 w63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
  w8 O3 J& Z% w* @* z70 Immunization in developing countries 1369
71 Community immunity 1395
# I! b# J% @2 b  C72 Economic analyses of vaccine policies 1413
3 x+ O3 i+ y- R4 Y1 r5 s73 Regulation and testing of vaccines 1427
# Q1 S7 I) j5 d! X0 N74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
! u* O8 w) ]+ q" \( a* B( E76 Vaccine safety 1464
& ?7 u  ?! s& K0 r77 Legal issues . 1481
78 Ethics 1508
) R" v: _5 i0 ?- u7 }

casarett

Vaccines, 6e, 2012

. H6 ]1 `% Z0 u3 WHardcover: 1570 pages
# j) i9 }. b9 z) Q7 l5 sPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
ISBN-10: 1455700908
1 r: C+ A6 ]5 t( dSize: 52.3mb (original pdf)
2 `4 ]) [2 m! ]  G% @
2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
, |5 p* o# S& p/ s, V
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
- [  T  [' P1 pAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
2 e$ g7 l9 Z3 \0 s$ l) x0 TClearly visualize concepts and objective data through an abundance of tables and figures.
* F6 v/ d/ A; N+ x2 f" w. @; g, wPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
+ Q( [5 K2 C4 Q
: ]' [3 z- B4 \- ~2 @# D, G0 S  FDownload link: http://pan.baidu.com/s/1i5NxwLR
' @' @& s! E0 t1 @" @% ^, ~+ G! BCode for downloading: dv96